Butorphanol for Pain Relief After Cesarean Section: A Retrospective Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

2500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-09-20

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study explored the association between postoperative functional recovery and the formula of analgesic pumps as well as other related factors (such as age, intraoperative blood loss, operation duration, etc.) by retrospectively analyzing the clinical data of patients undergoing cesarean section in the main campus and branches of Sichuan Provincial People's Hospital from September 2024 to June 2025. The value of this study lies in: 1) providing a basis for optimizing the postoperative analgesia plan after cesarean section. 2) To provide references for the formulation of personalized analgesia strategies in clinical practice, improve the postoperative recovery quality of patients, promote the concept of enhanced recovery after surgery, and reduce the medical burden.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Analgesic Effect of Butorphanol After Cesarean Section

NCT04490980

Analgesia

UNKNOWN NA

Intravenous Dexmedetomidine for Cesarean Section

NCT03065530

Breast Feeding Analgesia Obstetrical Postoperative Pain

COMPLETED PHASE4

Comparison of the Effects of Hydromorphone and Nalbuphine Patient Controlled Analgesia in Postoperative Pain After Cesarean Section

NCT06716359

Postoperative Pain Patiet Controlled Analgesia

ENROLLING_BY_INVITATION

Hydromorphone Hydrochloride Epidural Preemptive Analgesia for Postoperative Pain After Cesarean Section

NCT06823180

Post-surgical Pain

COMPLETED PHASE4

A Clinical Study on the Effect of Labor Analgesia on the Postpartum Recovery Outcome of Chinese Parturients

NCT05666024

Analgesia Labor Analgesia

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Caesarean Section

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

The group using the analgesic pump

An postoperative analgesic pump was used

Intervention Type DRUG

The drugs in the analgesic pump include butorphanol, hydromorphone, tramadol, and other medications.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

An postoperative analgesic pump was used

The drugs in the analgesic pump include butorphanol, hydromorphone, tramadol, and other medications.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age 18-55 years
2. ASAI-III level
3. Scheduled or emergency cesarean section
4. Postoperative use of analgesic pump (formulation includes buprenorphine or tramadol or hydromorphone, etc.)
5. Complete electronic medical records